Amphastar Pharmaceuticals, Inc. (AMPH)
NASDAQ: AMPH · Real-Time Price · USD
27.52
+0.54 (2.00%)
Sep 18, 2025, 2:40 PM EDT - Market open
Amphastar Pharmaceuticals Employees
Amphastar Pharmaceuticals had 2,028 employees as of December 31, 2024. The number of employees increased by 267 or 15.16% compared to the previous year.
Employees
2,028
Change (1Y)
267
Growth (1Y)
15.16%
Revenue / Employee
$356,351
Profits / Employee
$66,424
Market Cap
1.28B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2,028 | 267 | 15.16% |
| Dec 31, 2023 | 1,761 | 146 | 9.04% |
| Dec 31, 2022 | 1,615 | -146 | -8.29% |
| Dec 31, 2021 | 1,761 | -219 | -11.06% |
| Dec 31, 2020 | 1,980 | -47 | -2.32% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
AMPH News
- 21 days ago - Amphastar Pharmaceuticals to Present at the 2025 Wells Fargo Healthcare Conference - Accesswire
- 5 weeks ago - Amphastar Secures FDA Nod For Iron Sucrose Injection, Analysts Eye Major Sales Momentum - Benzinga
- 5 weeks ago - Amphastar Pharmaceuticals Bolsters Proprietary Pipeline Through Exclusive Licensing Agreement with Nanjing Anji Biotechnology Co., Ltd. - Accesswire
- 5 weeks ago - Amphastar Announces FDA Approval for Iron Sucrose Injection, USP - Accesswire
- 5 weeks ago - Amphastar Pharmaceuticals, Inc. (AMPH) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended June 30, 2025 - Accesswire
- 7 weeks ago - Amphastar Pharmaceuticals: Shares Are Interesting, And Options Even More - Seeking Alpha
- 7 weeks ago - Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 7th, 2025 - Accesswire